CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells
In this webinar, Dr. Mark DeWitt, Postdoctoral Fellow at University of California, discuss the use of gene editing techniques for hematopoietic stem and progenitor cells (HSPCs).
Publish Date: June 26, 2018
Views: 0
Related Multimedia
-
1:06:52New Tools for the Ex Vivo Expansion of Human Hematopoietic Stem and Progenitor Cells
Publish Date: March 09, 2015 -
46:01Targeting Self-Renewal Function in Normal Hematopoietic and Leukemic Stem Cells
Publish Date: February 03, 2017 -
71:57Using CRISPR/Cas9 to Model Stem Cell Organization and Dynamics
Publish Date: August 25, 2017
Explore Our Products
-
Serum-free culture supplement for expansion of human hematopoietic cells -
Cas9 nuclease for the generation of double-strand breaks in CRISPR-Cas9 genome editing -
ArciTect™ Human HPRT Positive Control Kit
Positive control for CRISPR-Cas9 genome editing -
StemSpan™-ACF Without Phenol Red
cGMP medium, for culture and expansion of human hematopoietic cells